Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_1

20%

Ph phase_2

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(2)

Detailed Status

Completed3

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (20.0%)

Phase 24 (80.0%)

Trials by Status

unknown240%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_2

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454

unknownphase_2

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

NCT00410462

completedphase_1

Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00060203

completedphase_2

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00041249

unknownphase_2

Brostallicin Clinical Trial for Myxoid Liposarcoma

NCT00633165

Clinical Trials (5)

Showing 5 of 5 trials

NCT01091454Phase 2

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Completed

NCT00410462Phase 2

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Unknown

NCT00060203Phase 1

Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma

Completed

NCT00041249Phase 2

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Completed

NCT00633165Phase 2

Brostallicin Clinical Trial for Myxoid Liposarcoma

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5